局部晚期直肠癌放疗的省略：迈向以患者为中心的治疗决策的一步。 - Suppr

Suppr

超能文献

Omission of Radiotherapy for Locally Advanced Rectal Cancer: A Step Toward Patient-Centric Treatment Decision-Making.

作者信息

Dossa Fahima, Weiser Martin R

机构信息

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Ann Surg Oncol. 2024 Oct;31(10):6337-6341. doi: 10.1245/s10434-024-16032-y. Epub 2024 Aug 16.

DOI:10.1245/s10434-024-16032-y

PMID:39150616

Abstract

摘要

相似文献

Omission of Radiotherapy for Locally Advanced Rectal Cancer: A Step Toward Patient-Centric Treatment Decision-Making.局部晚期直肠癌放疗的省略：迈向以患者为中心的治疗决策的一步。

Ann Surg Oncol. 2024 Oct;31(10):6337-6341. doi: 10.1245/s10434-024-16032-y. Epub 2024 Aug 16.

[Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].局部晚期直肠黏液腺癌放疗联合手术的疗效分析：一项基于监测、流行病学和最终结果人群数据的回顾性研究

Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):85-93.

Adjuvant radiation therapy of rectal cancer.

J Clin Oncol. 2001 Sep 1;19(17):3709-11. doi: 10.1200/JCO.2001.19.17.3709.

T3N0 Rectal Cancer: Radiation for All, None, or Some?T3N0 直肠癌：全部放疗，还是不放疗，或者部分放疗？

Cancer J. 2024;30(4):232-237. doi: 10.1097/PPO.0000000000000726.

Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients.局部晚期直肠癌：老年患者的治疗方法。

Curr Treat Options Oncol. 2020 Jan 11;21(1):1. doi: 10.1007/s11864-019-0692-8.

Observational study of decision making concerning radiotherapy in rectal cancer.直肠癌放疗决策的观察性研究。

Int J Surg. 2014;12(5):390-3. doi: 10.1016/j.ijsu.2014.03.016. Epub 2014 Mar 28.

Effectiveness of neoadjuvant radiotherapy in the treatment of locally advanced rectal cancer: a single-center experience in 263 patients.新辅助放疗治疗局部进展期直肠癌的疗效：263 例单中心经验。

Dig Surg. 2010 Aug;27(3):217-23. doi: 10.1159/000274459. Epub 2010 Jun 22.

Clinical characteristics and outcomes in patients with advanced rectal cancer: a national prospective cohort study.晚期直肠癌患者的临床特征与结局：一项全国性前瞻性队列研究。

Dis Colon Rectum. 2007 Mar;50(3):285-91. doi: 10.1007/s10350-006-0770-4.

Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?循环肿瘤DNA作为指导术后局部晚期直肠癌治疗的生物标志物：最佳选择？

Expert Rev Mol Diagn. 2018 Jan;18(1):1-3. doi: 10.1080/14737159.2018.1386558. Epub 2017 Oct 6.

Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus.2019冠状病毒病大流行期间局部晚期直肠癌管理的建议：伊朗共识

J Gastrointest Cancer. 2020 Sep;51(3):800-804. doi: 10.1007/s12029-020-00454-4.

本文引用的文献

Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.总新辅助治疗的直肠癌患者临床反应分级的器官保存和生存：OPRA 随机临床试验的二次分析。

JAMA Netw Open. 2024 Jan 2;7(1):e2350903. doi: 10.1001/jamanetworkopen.2023.50903.

Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).在 PROSPECT 试验（Alliance N1048）中局部晚期直肠癌治疗期间和治疗后的患者报告结局。

J Clin Oncol. 2023 Jul 20;41(21):3724-3734. doi: 10.1200/JCO.23.00903. Epub 2023 Jun 4.

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial.短程放疗联合化疗和手术与长程放化疗和手术的局部区域失败比较：RAPIDO 试验的 5 年随访。

Ann Surg. 2023 Oct 1;278(4):e766-e772. doi: 10.1097/SLA.0000000000005799. Epub 2023 Jan 20.

Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.新辅助化疗 CAPOX 对比放化疗治疗未累及中胚层筋膜的局部进展期直肠癌（CONVERT）：一项 III 期试验的初步结果。

Ann Surg. 2023 Apr 1;277(4):557-564. doi: 10.1097/SLA.0000000000005780. Epub 2022 Dec 20.

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.直肠癌患者接受全新辅助治疗后的器官保存。

J Clin Oncol. 2022 Aug 10;40(23):2546-2556. doi: 10.1200/JCO.22.00032. Epub 2022 Apr 28.

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.局部晚期直肠癌患者的 FOLFIRINOX 新辅助化疗和术前放化疗（UNICANCER-PRODIGE 23）：一项多中心、随机、开放标签、III 期临床试验。

Lancet Oncol. 2021 May;22(5):702-715. doi: 10.1016/S1470-2045(21)00079-6. Epub 2021 Apr 13.

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.短程放疗联合化疗后行全直肠系膜切除术（TME）与术前放化疗、TME 及辅助化疗在局部进展期直肠癌（RAPIDO）中的应用：一项随机、开放标签、3 期临床试验。

Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020 Dec 7.

Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial.新辅助改良 FOLFOX6 联合或不联合放疗对比氟尿嘧啶联合放疗治疗局部进展期直肠癌：中国 FOWARC 试验的最终结果。

J Clin Oncol. 2019 Dec 1;37(34):3223-3233. doi: 10.1200/JCO.18.02309. Epub 2019 Sep 26.

Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial.使用磁共振成像标准识别适合原发性手术的“预后良好”直肠癌患者的安全性和可行性：第 2 阶段非随机快速银临床试验。

JAMA Oncol. 2019 Jul 1;5(7):961-966. doi: 10.1001/jamaoncol.2019.0186.

Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial.OCUM 直肠癌试验中基于 MRI 选择新辅助放化疗的肿瘤学结果。

Br J Surg. 2018 Oct;105(11):1519-1529. doi: 10.1002/bjs.10879. Epub 2018 May 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验